Get the full picture
Sign in to uncover key details.
Nimbus Therapeutics
Manufacturing · Massachusetts, United States · 51-200 Employees
View Company Info for Free
Overview
Headquarters
130 Prospect St Ste 301, Cambridge, Mass...Phone Number
(857) 999-2009Website
www.nimbustx.comRevenue
$16.9 MillionIndustry
About Nimbus Therapeutics
Nimbus Therapeutics specializes in the design and development of highly selective small molecule medicines aimed at improving patient outcomes in oncology, immunology, and metabolic diseases. The company employs advanced computational drug design and a meticulous approach to target selection, ensuring their products are both effective and innovative. With a strong track record of success, Nimbus is committed to pushing the boundaries of medicine through cutting-edge technologies and world-class expertise. Their intended clients include patients in need of novel treatments and healthcare partners seeking collaboration in drug development.Explore more
Nimbus Therapeutics Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Compare Similar Companies to Nimbus Therapeutics
Compare insights from companies similar to Nimbus Therapeutics, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
$11.9M
51-200
Private
<$5M
1996
DG
Daniel GaoCEO of Joinn Lab, Member of Executive Steering Committee of Biomere
Nimbus Therapeutics Tech Stack
A closer look at the technologies used by Nimbus Therapeutics
See more technologies
Top Manufacturing Companies
Top companies in Australia by revenue
Frequently Asked Questions Regarding Nimbus Therapeutics
Sign Up For FreeTo access detailed company insights
Nimbus Therapeutics specializes in the design and development of highly selective small molecule medicines aimed at improving patient outcomes in oncology, immunology, and metabolic diseases. The company employs advanced computational drug design and a meticulous approach to target selection, ensuring their products are both effective and innovativ... Read More
